ABD - İngilizce - NLM (National Library of Medicine)

dispensing solutions inc. - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan succinate 50 mg - sumatriptan succinate tablets are indicated for the acute treatment of migraine attacks with or without aura in adults. sumatriptan succinate tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see contraindications). safety and effectiveness of sumatriptan succinate tablets have not been established for cluster headache, which is present in an older, predominantly male population. sumatriptan succinate tablets should not be given to patients with history, symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes. in addition, patients with other significant underlying cardiovascular diseases should not receive sumatriptan succinate tablets . ischemic cardiac syndromes include, but are not limited to, angina pectoris of any type (e.g., stable angina of effort and vasospastic forms of angina such as the prinzmetal variant), all forms of myocardial infarction, and silent myocardial ischemia. cerebrovasc

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sumatriptan succinate, quantity: 140 mg (equivalent: sumatriptan, qty 100 mg) - tablet, multilayer - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; lactose - acute relief of migraine attacks with or without aura. there is no information available on the use of sumatriptan in the treatment of basilar or hemiplegic migraine.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sumatriptan succinate, quantity: 70 mg (equivalent: sumatriptan, qty 50 mg) - tablet, multilayer - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; magnesium stearate; lactose - acute relief of migraine attacks with or without aura. there is no information available on the use of sumatriptan in the treatment of basilar or hemiplegic migraine.

İsrail - İbranice - Ministry of Health

glaxo smith kline (israel) ltd - sumatriptan as succinate - טבליות מצופות פילם - sumatriptan as succinate 100 mg - sumatriptan - sumatriptan - acute relief of migraine attacks with or without aura. for the acute treatment of migraine attacks associated with women's menstrual cycle.

İsrail - İbranice - Ministry of Health

glaxo smith kline (israel) ltd - sumatriptan as succinate - טבליות מצופות פילם - sumatriptan as succinate 50 mg - sumatriptan - sumatriptan - acute relief of migraine attacks with or without aura. for the acute treatment of migraine attacks associated with women's menstrual cycle.

İsrail - İbranice - Ministry of Health

glaxo smith kline (israel) ltd - sumatriptan as succinate - תמיסה להזרקה - sumatriptan as succinate 6 mg / 0.5 ml - sumatriptan - sumatriptan - acute relief of migraine attacks with or without aure, cluster headache. for the acute treatment of migraine attacks associated with women's menstrual cycle.

Hollanda - Hollandaca - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

sandoz b.v. veluwezoom 22 1327 ah almere - sumatriptansuccinaat samenstelling overeenkomend met ; ; sumatriptan 100 mg/stuk - tablet - ammoniomethacrylaatcopolymeer type a ; arabische gom (e 414) ; carmellose natrium (e 466) ; cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; grapefruit flavour 11473-71 (ri) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maltodextrine, ammoniomethacrylaatcopolymeer type a ; arabische gom (e 414) ; carmellose natrium (e 466) ; cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; grapefruit flavour 11473-71 (ri) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maltodextrine, - sumatriptan

Hollanda - Hollandaca - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

sandoz b.v. veluwezoom 22 1327 ah almere - sumatriptansuccinaat samenstelling overeenkomend met ; ; sumatriptan 50 mg/stuk - tablet - ammoniomethacrylaatcopolymeer type a ; arabische gom (e 414) ; carmellose natrium (e 466) ; cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; grapefruit flavour 11473-71 (ri) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maltodextrine, ammoniomethacrylaatcopolymeer type a ; arabische gom (e 414) ; carmellose natrium (e 466) ; cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; grapefruit flavour 11473-71 (ri) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; maltodextrine, - sumatriptan

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - sumatriptan succinate -

ABD - İngilizce - NLM (National Library of Medicine)

unit dose services - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 100 mg - sumatriptan tablets are indicated for the acute treatment of migraine attacks with or without aura in adults. sumatriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see contraindications ). safety and effectiveness of sumatriptan tablets have not been established for cluster headache, which is present in an older, predominantly male population. sumatriptan tablets should not be given to patients with history, symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes. in addition, patients with other significant underlying cardiovascular diseases should not receive sumatriptane tablets. ischemic cardiac syndromes include, but are not limited to, angina pectoris of any type (e.g., stable angina of effort, vasospastic forms of angina such as the prinzmetal variant), all forms of myocardial infarction, and silent myocardial ischemia. cerebrovascular syndromes include, but are not limited to, stro